Clinical trials search and NCT lookup from ClinicalTrials.gov: status, phase, sp...
https://api.boscolabs.dev/v1/clinical-trialsOverview
Clinical trials search and NCT lookup from ClinicalTrials.gov: status, phase, sponsor, conditions, interventions, enrollment, start and primary completion dates, countries and results. $0.004 per trial, min $0.005. upto: pay only for delivered rows; exact: pays the quote (default 10 rows; set maxResults). Nothing is settled on an error or empty result. Official sources, source link per row.
Protocol
x402 (POST)
Price
$0.04
Payment Asset
USD Coin
Payment Network
eip155:8453
Category
tools/search
Provider
Clinical Trials Search & NCT
Source
bazaar
Indexed
2026-11-06 23:08:01
Health
Status
unknown
Latency (p50)
—
Uptime (30d)
—
Reliability Score
—
Last Checked
Never
Last Healthy
Never
Consecutive Failures
0
x402 Payment Validation
Payment Requirements
—
Asset Verified
—
Facilitator
—
Input Schema
{
"body": {
"condition": "obesity",
"intervention": "semaglutide OR tirzepatide",
"locationCountries": [
"Europe"
],
"phase": [
"PHASE3"
],
"status": [
"RECRUITING"
]
},
"bodyType": "json",
"method": "POST",
"type": "http"
}
Output Schema
{
"example": {
"charged_usd": 0.005,
"count": 1,
"message": "1 row returned with its source link; $0.005 settled.",
"paid_via": "x402",
"rows": [
{
"acronym": null,
"arms": null,
"attribution": "Source: ClinicalTrials.gov, a U.S. Government database of the National Librar...",
"brief_summary": "This study will look at how well the new medicine CagriSema helps people with...",
"collaborators": [],
"completion_date": "2025-03-07",
"completion_date_type": "ACTUAL",
"conditions": [
"Obesity or Overweight"
],
"countries": [
"Japan"
],
"data_processed_at": "2026-11-05T10:00:06",
"eligibility": null,
"enrollment_count": 331,
"enrollment_type": "ACTUAL",
"has_results": false,
"interventions": [
{
"name": "Cagrilintide",
"type": "DRUG"
}
],
"last_update_posted": "2026-01-22",
"nct_id": "NCT05813925",
"phases": [
"PHASE3"
],
"primary_completion_date": "2025-01-17",
"primary_completion_date_type": "ACTUAL",
"primary_outcomes": [
{
"measure": "Relative Change in Body Weight",
"time_frame": "From baseline (week 0) to end of treatment (week 68)"
}
],
"primary_outcomes_total": 1,
"results_first_posted": null,
"retrieved_at": "2026-11-05T22:38:47+00:00",
"schema_version": "1",
"secondary_outcomes": null,
"site_count": 28,
"sites": null,
"source_url": "https://clinicaltrials.gov/study/NCT05813925",
"sponsor": "Novo Nordisk A/S",
"sponsor_class": "INDUSTRY",
"start_date": "2023-04-03",
"start_date_type": "ACTUAL",
"status": "COMPLETED",
"study_type": "INTERVENTIONAL",
"title": "A Research Study to See How Well CagriSema Helps People in East Asia With Exc..."
}
],
"tool": "clinical-trials",
"warnings": []
},
"type": "json"
}